Back
Amplify Energy Vs. Spyre Therapeutics Industry Stock Comparison
Sell
20
AMPY
Amplify Energy
Last Price:
5.86
Seasonality Move:
-13.44%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
20
Amplify Energy (AMPY)
is a Sell
Is Amplify Energy a Buy, Sell or Hold?
- The current Amplify Energy [AMPY] share price is $5.85. The Score for AMPY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- AMPY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMPY Stock Price Chart
What is Amplify Energy's stock price today?
-
The Amplify Energy share price today is $5.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPY is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
AMPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 40.59 | Sell |
| Chaikin Money Flow: | 56135 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.89 - 6.29) | Sell |
| Bollinger Bands (100): | (5.9 - 6.88) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 31.35 | Sell |
| Chaikin Money Flow: | -1780910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.05 - 37.75) | Sell |
| Bollinger Bands (100): | (27.4 - 39.18) | Sell |
AMPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.91 | Sell |
| 20-day SMA: | 6.06 | Sell |
| 50-day SMA: | 6.58 | Sell |
| 200-day SMA: | 6.44 | Sell |
| 8-day EMA: | 5.91 | Sell |
| 20-day EMA: | 6.07 | Sell |
| 50-day EMA: | 6.31 | Sell |
| 200-day EMA: | 6.49 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.63 | Sell |
| 20-day SMA: | 34.16 | Sell |
| 50-day SMA: | 35.1 | Sell |
| 200-day SMA: | 24.22 | Buy |
| 8-day EMA: | 32.34 | Sell |
| 20-day EMA: | 33.91 | Sell |
| 50-day EMA: | 34.32 | Sell |
| 200-day EMA: | 27.18 | Sell |
Amplify Energy Earnings Growth & AMPY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.00 per share, and an increase next year of $0.80 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Amplify Energy Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||